# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086092
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:51
Documents
90
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | f10q0923_immucell.htm iXBRL | 10-Q | 1177040
2 | CERTIFICATION | f10q0923ex31_immucell.htm | EX-31 | 9767
3 | CERTIFICATION | f10q0923ex32_immucell.htm | EX-32 | 4846
| Complete submission text file | 0001213900-23-086092.txt |  | 7302875

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | iccc-20230930.xsd | EX-101.SCH | 74532
5 | XBRL CALCULATION FILE | iccc-20230930_cal.xml | EX-101.CAL | 39139
6 | XBRL DEFINITION FILE | iccc-20230930_def.xml | EX-101.DEF | 327756
7 | XBRL LABEL FILE | iccc-20230930_lab.xml | EX-101.LAB | 628495
8 | XBRL PRESENTATION FILE | iccc-20230930_pre.xml | EX-101.PRE | 345908
84 | EXTRACTED XBRL INSTANCE DOCUMENT | f10q0923_immucell_htm.xml | XML | 1128347

Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 231398606
SIC: 2835 In Vitro & In Vivo Diagnostic Substances